Medigene AG
Stock Forecast, Prediction & Price Target
Medigene AG Financial Estimates
Medigene AG Revenue Estimates
Medigene AG EBITDA Estimates
Medigene AG Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| €10.46M N/A | €31.24M 198.64% | €6.03M -80.68% | Avg: €6.95M Low: €6.95M High: €6.95M avg. 15.18% | Avg: €15.9M Low: €15.9M High: €15.9M avg. 128.77% | Avg: €20M Low: €20M High: €20M avg. 25.78% | Avg: €15M Low: €15M High: €15M avg. -25% |
Net Income
% change YoY
| €-9.98M N/A | €-8.33M 16.55% | €-16.17M -94.20% | Avg: €-13.98M Low: €-13.98M High: €-13.98M avg. 13.52% | Avg: €-7.50M Low: €-7.50M High: €-7.50M avg. 46.38% | Avg: €-5.69M Low: €-5.69M High: €-5.69M avg. 24.13% | Avg: €-9.31M Low: €-9.31M High: €-9.31M avg. -63.63% |
EBITDA
% change YoY
| €-7.08M N/A | €12.73M 279.75% | €-15.54M -222.10% | Avg: €-4.54M Low: €-4.54M High: €-4.54M avg. 70.76% | Avg: €-10.39M Low: €-10.39M High: €-10.39M avg. -128.77% | Avg: €-13.07M Low: €-13.07M High: €-13.07M avg. -25.78% | Avg: €-9.80M Low: €-9.80M High: €-9.80M avg. 25.00% |
EPS
% change YoY
| -$0.39 N/A | -$0.32 17.94% | -$1.32 -312.5% | Avg: -$0.54 Low: -$0.54 High: -$0.54 avg. 59.02% | Avg: -$0.29 Low: -$0.29 High: -$0.29 avg. 46.38% | Avg: -$0.22 Low: -$0.22 High: -$0.22 avg. 24.13% | Avg: -$0.36 Low: -$0.36 High: -$0.36 avg. -63.63% |
Operating Expenses
% change YoY
| €16.18M N/A | €16.53M 2.13% | €20.54M 24.24% | Avg: €5.76M Low: €5.76M High: €5.76M avg. -71.92% | Avg: €13.19M Low: €13.19M High: €13.19M avg. 128.77% | Avg: €16.59M Low: €16.59M High: €16.59M avg. 25.78% | Avg: €12.44M Low: €12.44M High: €12.44M avg. -24.99% |
FAQ
What is Medigene AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 5.10% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -13.98M, average is -13.98M and high is -13.98M.
What is Medigene AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 36.18% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is €6.95M, average is €6.95M and high is €6.95M.
What is Medigene AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.47% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.54, average is -$0.54 and high is €-0.54.